Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective Review

Infectious Diseases and Therapy

Volumn 3, Issue 2, 2014, Pages 245-256

  Rolston, Kenneth V I ^a   Nesher, Lior ^a   Tarrand, Jeffrey T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Gram negative bacteria; Gram positive bacteria; Hematologic malignancies; Surgical site infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; DAPTOMYCIN; QUINOLONE; RIFAMPICIN; VANCOMYCIN;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BREAST CANCER; CANCER SURGERY; CRANIOTOMY; DRUG SENSITIVITY; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; NEOPLASM; NONHUMAN; PELVIS SURGERY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SOLID TUMOR; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS INFECTION; SURGICAL INFECTION; THORACOTOMY; WOUND INFECTION;

BACILLI (CLASS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84977107110     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-014-0048-4     Document Type: Article

References (28)

1. Baden LR, Bensinger W, Angarone M, et al. Prevention and treatment of cancer-related infections. J Natl Compr Cancer Netw. 2012;10:1412–45.
2. Safdar A, Armstrong D. Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis. 2011;53:798–806.
3. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56–93.
4. Jacobson K, Rolston K, Elting L, LeBlanc B, Whimbey E, Ho DH. Susceptibility surveillance among Gram-negative bacilli at a cancer center. Chemotherapy. 1999;45:325–34.
5. Rolston KV. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis. 2005;40(Suppl 4):S246–52.
6. Sutton SH. Infections associated with solid malignancies. Cancer Treat Res. 2014;161:371–411.
7. Brahmbhatt RD, Huebner M, Scow JS, et al. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012;19:3205–11.
8. Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev. 2013;11:CD005571.
9. Mahajan SN, Ariza-Heredia EJ, Rolston KV, et al. Perioperative antimicrobial prophylaxis for intra-abdominal surgery in patients with cancer: a retrospective study comparing ertapenem and nonertapenem antibiotics. Ann Surg Oncol. 2014;21:513–9.
10. Walcott BP, Redjal N, Coumans JV. Infection following operations on the central nervous system: deconstructing the myth of the sterile field. Neurosurg Focus. 2012;33:E8.
11. Murray PR BE, Phaller A, Tenover FC, Yolken RH, editors. Manual of clinical microbiology, 9th ed. Washington: ASM; 2007.
12. LaSala PR, Segal J, Han FS, Tarrand JJ, Han XY. First reported infections caused by three newly described genera in the family Xanthomonadaceae. J Clin Microbiol. 2007;45:641–4.
13. CLS M100-S18M-aM-A. Performance standards for antimicrobial susceptibility testing: eighteen informational 305 supplement. Wayne: Clinical and Laboratory Standards Institute; 2008.
14. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606–8.
15. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;1999(20):250–78.
16. Avritscher EB, Cooksley CD, Rolston KV, et al. Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume. Support Care Cancer. 2014;22:527–35.
17. Dominioni L, Imperatori A, Rotolo N, Rovera F. Risk factors for surgical infections. Surg Infect (Larchmt). 2006;7(Suppl 2):S9–12.
18. Korinek AM, Golmard JL, Elcheick A, et al. Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal of antibiotic prophylaxis on 4,578 patients. Br J Neurosurg. 2005;19:155–62.
19. Sturgis TM, Yancy W, Cole JC, Proctor DD, Minhas BS, Marcuard SP. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol. 1996;91:2301–4.
20. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;1999(27):97–132.
21. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis. 2005;5:94–106.
22. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42:2398–402.
23. Mahajan SN, Shah JN, Hachem R, et al. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012;17:1329–36.
24. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:193–200.
25. Mukhtar RA, Throckmorton AD, Alvarado MD, et al. Bacteriologic features of surgical site infections following breast surgery. Am J Surg. 2009;198:529–31.
26. Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller L. Breast implant infections: is cefazolin enough? Plast Reconstr Surg. 2010;126:779–85.
27. Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007;45:228–33.
28. Viola GM, Raad II, Rolston KV. Breast tissue expander-related infections: perioperative antimicrobial regimens. Infect Control Hosp Epidemiol. 2014;35:75–81.